Association of tobacco use and cessation with coronary atherosclerosis

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author CHEEZUM, Michael K.
KIM, Alexander
BITTENCOURT, Marcio S. FMUSP-HC
KASSOP, David
NISSEN, Alexander
THOMAS, Dustin M.
Binh Nguyen
GLYNN, Robert J.
SHAH, Nishant R.
VILLINES, Todd C.
dc.date.issued 2017
dc.identifier.citation ATHEROSCLEROSIS, v.257, p.201-207, 2017
dc.identifier.issn 0021-9150
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/21608
dc.description.abstract Background and aims: The impact of tobacco use and cessation on atherogenesis remains unclear. We aimed to study the association of tobacco use and prior cessation with the presence, extent and severity of atherosclerosis on coronary computed tomographic angiography (CTA). Methods: We examined 1798 consecutive symptomatic patients without known coronary artery disease (CAD) referred for CTA, stratified by smoking status (never, current [within 30 days], or former [>30 days before CTA]). Plaque severity (none, <50%, >= 50% stenosis), composition (non-calcified [NCP], partially calcified [PCP], or calcified plaque [CP]), and segment involvement score (SIS) were visually graded. Multivariate analysis was performed, adjusting for CAD risk factors and cholesterol lowering medication use. Results: The median age of patients was 50 years [IQR: 42-58] (61% male), with 74% never smokers, 12% current smokers, and 14% former smokers (median quit duration = 12 years [IQR: 3-26]). Smoking exposure in former versus current smokers was 11 [IQR: 5-25] and 10 [IQR: 2-20] pack-years, respectively (p = 0.01). Compared to never smokers, current smokers demonstrated an increased odds ratio of all plaque types (adjusted OR: any NCP = 1.55 [95% CI 1.04-2.32], p = 0.03; any PCP = 1.61 [1.10-2.37], p = 0.02; any CP = 1.93 [1.32-2.81], p = 0.001), non-obstructive CAD (aOR = 1.47 [1.04, 2.07], p = 0.03), obstructive CAD (aOR = 1.81 [1.01-3.24], p = 0.047), and SIS > 4 (aOR = 1.60 [1.04e2.46], p = 0.03). Compared to current smoking, prior smoking cessation (>= 12 years) was associated with a decreased odds ratio of any NCP (aOR = 0.42 [0.19-0.90], p = 0.03), CP (aOR = 0.43 [0.22-0.84], p = 0.02), and obstructive CAD (aOR = 0.40, [0.15-0.98], p = 0.048). Conclusions: Current smoking is independently associated with the presence and extent of coronary plaque, and a higher risk of non-obstructive and obstructive CAD compared to never smoking. Prior smoking cessation correlated with improvements in CTA-identified plaque measures.
dc.description.sponsorship · Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]
· Harvard University
· Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources)
dc.language.iso eng
dc.publisher ELSEVIER IRELAND LTD
dc.relation.ispartof Atherosclerosis
dc.rights restrictedAccess
dc.subject Atherosclerosis; Coronary computed tomographic angiography; Smoking; Tobacco; Coronary artery disease
dc.subject.other computed tomographic angiography; prognostic value; cardiovascular-disease; scct guidelines; ct angiography; risk-factors; smoking; diagnosis; micrornas; mortality
dc.title Association of tobacco use and cessation with coronary atherosclerosis
dc.type article
dc.rights.holder Copyright ELSEVIER IRELAND LTD
dc.identifier.doi 10.1016/j.atherosclerosis.2016.11.016
dc.identifier.pmid 27993385
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author BITTENCOURT, Marcio S.:HU:SCPACEX-62
hcfmusp.author.external · CHEEZUM, Michael K.:Walter Reed Natl Mil Med Ctr, Cardiol Serv, Dept Med, 8901 Rockville Pike, Bethesda, MD 20889 USA
· KIM, Alexander:Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
· KASSOP, David:Womack Army Med Ctr, Dept Med, Cardiol Serv, Ft Bragg, NC USA
· NISSEN, Alexander:Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
· THOMAS, Dustin M.:San Antonio Mil Med Ctr, Cardiol Serv, Dept Med, San Antonio, TX USA
· Binh Nguyen:Walter Reed Natl Mil Med Ctr, Dept Radiol, Bethesda, MD USA
· GLYNN, Robert J.:Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA
· VILLINES, Todd C.:Walter Reed Natl Mil Med Ctr, Cardiol Serv, Dept Med, 8901 Rockville Pike, Bethesda, MD 20889 USA
hcfmusp.origem.id WOS:000397405600027
hcfmusp.origem.id 2-s2.0-85008195296
hcfmusp.publisher.city CLARE
hcfmusp.publisher.country IRELAND
hcfmusp.relation.reference · Abbara Suhny, 2009, J Cardiovasc Comput Tomogr, V3, P190, DOI 10.1016/j.jcct.2009.03.004
· AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827
· Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047
· Bittencourt MS, 2014, CIRC-CARDIOVASC IMAG, V7, P282, DOI 10.1161/CIRCIMAGING.113.001047
· Chamberlain JJ, 2016, ANN INTERN MED, V164, P542, DOI 10.7326/M15-3016
· Cheezum MK, 2015, EUR HEART J-CARD IMG, V16, P1338, DOI 10.1093/ehjci/jev087
· Cheezum MK, 2013, JACC-CARDIOVASC IMAG, V6, P574, DOI 10.1016/j.jcmg.2012.11.016
· Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935
· Halliburton SS, 2011, J CARDIOVASC COMPUT, V5, P198, DOI 10.1016/j.jcct.2011.06.001
· Hulten EA, 2011, J AM COLL CARDIOL, V57, P1237, DOI 10.1016/j.jacc.2010.10.011
· Inoue Teruo, 2004, Tob Induc Dis, V2, P27, DOI 10.1186/1617-9625-2-1-27
· Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108
· James PA, 2014, JAMA-J AM MED ASSOC, V5, P507
· Jefferis BJ, 2010, ATHEROSCLEROSIS, V208, P550, DOI 10.1016/j.atherosclerosis.2009.07.044
· Kallio K, 2010, CIRC-CARDIOVASC QUAL, V3, P196, DOI 10.1161/CIRCOUTCOMES.109.857771
· Kim Jin, 2013, [Journal of the Korean Society of Cadastre, 한국지적학회지], V29, P1
· Le J, 2010, CIRC-CARDIOVASC IMAG, V3, P8, DOI 10.1161/CIRCIMAGING.109.880070
· Leipsic J, 2014, J CARDIOVASC COMPUT, V8, P342, DOI 10.1016/j.jcct.2014.07.003
· McEvoy J. W., 2015, VASC BIOL, V35, P1002
· Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067
· Mobarrez F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090314
· Nakanishi R, 2015, EUR HEART J, V36, P1031, DOI 10.1093/eurheartj/ehv013
· Novak J, 2015, ADV EXP MED BIOL, V887, P79, DOI 10.1007/978-3-319-22380-3_5
· Samanta S, 2016, TRENDS CARDIOVAS MED, V26, P407, DOI 10.1016/j.tcm.2016.02.004
· Shah Reena S, 2010, Expert Rev Cardiovasc Ther, V8, P917, DOI 10.1586/erc.10.56
· [Anonymous], 2007, IARC HDB CANC PREV, V11, P11
· US Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE
· van Domburg RT, 2000, J AM COLL CARDIOL, V36, P878, DOI 10.1016/S0735-1097(00)00810-X
· Wronska A, 2015, ACTA PHYSIOL, V213, P60, DOI 10.1111/apha.12416
· [Anonymous], 2002, CIRCULATION, V106, P3143
dc.description.index MEDLINE
dc.identifier.eissn 1879-1484
hcfmusp.citation.scopus 3
hcfmusp.citation.wos 2
hcfmusp.affiliation.country Brasil
hcfmusp.affiliation.country Estados Unidos


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics